$IBM surges 11% as Commerce Dept awards $1B CHIPS Act quantum foundry grant
Original: IBM just scored a $26 billion quantum windfall — and the stock's rally isn't over View original →
Deal Overview
The U.S. Commerce Department on May 22, 2026 awarded IBM a $1 billion grant under the CHIPS and Science Act's quantum computing sub-program, triggering an 11% single-session surge in $IBM shares and a $26 billion market cap gain. IBM will match the federal grant dollar-for-dollar, committing $1 billion of its own capital, for a total $2 billion investment in the Albany, New York facility named "Anderon."
What Anderon Is
Anderon will be America's first pure-play, dedicated 300mm quantum chip manufacturing foundry. Unlike conventional fabs that handle a mixed workload of logic and memory chips, the Albany facility is designed exclusively for quantum processors. The 300mm wafer platform — the same form factor used in high-volume classical semiconductor production — aims to bring manufacturing-scale cost efficiencies to quantum devices, a milestone the industry has yet to reach commercially.
Policy Context
The CHIPS and Science Act authorized $52 billion to rebuild U.S. semiconductor manufacturing. IBM's grant is drawn from a $2 billion sub-program dedicated specifically to quantum computing — separate from classical chip grants previously allocated to Intel, TSMC, and Samsung Electronics. Washington's dedicated quantum tranche signals intent to build a domestic quantum hardware manufacturing base independent of existing foundry networks.
Near-Term Financials
No immediate revenue impact is expected. IBM's Q2 FY2026 earnings (scheduled July–August 2026) will not reflect Anderon-related revenue, as the facility requires years to complete. The 11% stock reaction implies the market is pricing in strategic positioning value — IBM's designation as the anchor supplier for U.S. government quantum hardware procurement pipelines — rather than near-term cash flows.
What to Watch
- July–August 2026: IBM Q2 earnings — quantum business order-book disclosures
- Albany site regulatory approvals and groundbreaking timeline
- Allocation of remaining $1 billion in the CHIPS quantum sub-program
Source: Yahoo Finance
Not investment advice. Verify all figures with primary sources before acting.
Related Articles
IBM $IBM fell 6% in extended trading after first-quarter adjusted EPS of $1.91 and revenue of $15.92B beat expectations of $1.81 and $15.62B. The stock reaction turned negative because management kept its 2026 outlook unchanged instead of raising targets after a 9% revenue gain.
Greg Abel, Warren Buffett's successor at Berkshire Hathaway ($BRK.B), has invested approximately $2.8 billion in Delta Air Lines ($DAL) despite surging fuel costs pressuring the sector — a direct reversal of Buffett's 2020 pandemic-era exit from all airline positions. On the same day, Appaloosa Management disclosed it had sold its entire positions in Delta, American Airlines ($AAL), and United Airlines ($UAL).
Anthropic has raised $30 billion in its latest funding round led by Dragoneer, Greenoaks, Sequoia Capital, and Altimeter Capital — each contributing at least $2 billion — lifting its valuation to $900 billion and overtaking OpenAI's $852 billion private-market valuation. The company's annualized revenue has reached approximately $45 billion, a fivefold increase from the $9 billion pace at year-end 2025.
Comments (0)
No comments yet. Be the first to comment!